Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Insulin pump therapy for type 2 diabetes mellitus

The evidence base for the efficacy of insulin pump therapy in type 2 diabetes mellitus (T2DM) has been inconsistent to date. However, a recent large-scale randomized controlled trial comparing pump treatment with multiple daily insulin injections in patients with poorly controlled T2DM has shown substantial improvement in glycaemic control with pump therapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pickup, J. C. Insulin-pump therapy for type 1 diabetes mellitus. N. Engl. J. Med. 366, 1616–1624 (2012).

    Article  CAS  Google Scholar 

  2. National Institute for Health and Care Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE Technology Appraisals [TA151] [online], (2008).

  3. Raskin, P. et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26, 2598–2603 (2003).

    Article  CAS  Google Scholar 

  4. Berthe, E. et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous insulin infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm. Metab. Res. 39, 224–229 (2007).

    Article  CAS  Google Scholar 

  5. Reznik, Y. et al. Insulin pump treatment compared with multiple daily insulin injections for the treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet http://dx.doi.org/10.1016/S0140–6736(14)61037–0.

  6. Dodd, A. H. et al. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004. Curr. Med. Res. Opin. 25, 1605–1613 (2009).

    Article  CAS  Google Scholar 

  7. Edelman, S. et al. Insulin pump therapy in patients with type 2 diabetes. Safely improved glycemic control using a simple insulin dosing regimen. Diabet. Technol. Therapeut. 12, 627–633 (2010).

    Article  CAS  Google Scholar 

  8. Leinung, M. et al. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections. Endocr. Pract. 19, 9–13 (2013).

    Article  Google Scholar 

  9. Parkner, T. et al. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in type 2 diabetes. Diabet. Med. 25, 585–591 (2008).

    Article  CAS  Google Scholar 

  10. King, A. B., Clark, D. & Wolfe, G. S. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes. Diabet. Technol. Therapeut. 14, 900–903 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John C. Pickup.

Ethics declarations

Competing interests

J.C.P. has received speaker and/or consultancy fees from manufacturers of insulin pumps, including Cellnovo, Cequr, Medtronic and Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pickup, J. Insulin pump therapy for type 2 diabetes mellitus. Nat Rev Endocrinol 10, 647–649 (2014). https://doi.org/10.1038/nrendo.2014.142

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.142

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing